California State Teachers Retirement System lessened its position in Spectranetics Corp (NASDAQ:SPNC) by 8.8% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 76,843 shares of the medical equipment provider’s stock after selling 7,379 shares during the period. California State Teachers Retirement System owned approximately 0.18% of Spectranetics Corp worth $2,951,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Amalgamated Bank acquired a new stake in shares of Spectranetics Corp in the 2nd quarter worth about $213,000. Keybank National Association OH acquired a new stake in shares of Spectranetics Corp in the 2nd quarter worth about $235,000. BNP Paribas Arbitrage SA increased its holdings in shares of Spectranetics Corp by 202.9% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 6,433 shares of the medical equipment provider’s stock worth $247,000 after acquiring an additional 4,309 shares during the period. BlueCrest Capital Management Ltd acquired a new stake in shares of Spectranetics Corp in the 2nd quarter worth about $258,000. Finally, Aperio Group LLC acquired a new stake in shares of Spectranetics Corp in the 2nd quarter worth about $261,000. 91.95% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: “California State Teachers Retirement System Has $2.95 Million Position in Spectranetics Corp (SPNC)” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this report on another publication, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this report can be read at https://www.thecerbatgem.com/2017/11/10/california-state-teachers-retirement-system-has-2-95-million-position-in-spectranetics-corp-spnc.html.

Spectranetics Corp (NASDAQ SPNC) opened at $38.45 on Friday. The company has a quick ratio of 1.43, a current ratio of 1.92 and a debt-to-equity ratio of 7.61. Spectranetics Corp has a 52 week low of $19.80 and a 52 week high of $38.55.

SPNC has been the topic of a number of analyst reports. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $27.00 price objective on shares of Spectranetics Corp in a report on Monday, July 24th. Raymond James Financial, Inc. reaffirmed a “market perform” rating and issued a $28.00 price objective on shares of Spectranetics Corp in a report on Tuesday, July 25th. Stifel Nicolaus cut shares of Spectranetics Corp from a “buy” rating to a “hold” rating in a report on Thursday, August 3rd. Needham & Company LLC cut shares of Spectranetics Corp from a “buy” rating to a “hold” rating in a report on Friday, August 4th. Finally, Guggenheim cut shares of Spectranetics Corp from a “buy” rating to a “neutral” rating in a report on Friday, August 4th. Ten investment analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Spectranetics Corp presently has an average rating of “Hold” and a consensus target price of $35.36.

Spectranetics Corp Company Profile

The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company’s products are used to cross, prepare and treat arterial blockages in the heart and legs and to manage pacemaker and defibrillator cardiac leads.

Want to see what other hedge funds are holding SPNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Spectranetics Corp (NASDAQ:SPNC).

Institutional Ownership by Quarter for Spectranetics Corp (NASDAQ:SPNC)

Receive News & Stock Ratings for Spectranetics Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectranetics Corp and related stocks with our FREE daily email newsletter.